Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Xarelto Tested FDA’s Comparative Efficacy Powers, But Conservative View Prevailed

May 01 2012

• By Bridget Silverman

Related Content

<i>Pradaxa</i> Review Shows FDA Doubts About The Power Of REMS To Change Prescribing Practices

Apr 01 2011

Boehringer Will Test How <em>Pradaxa</em> Stacks Up To The Competition In Real-World Study

May 01 2012

ROCKET AF’s Design Causes Headaches For <i>Xarelto</i> Sponsors

Sep 19 2011

<i>Xarelto</i> Review Puts FDA’s Comparative Effectiveness Stance To The Test

Sep 19 2011

Related Companies

Johnson & Johnson

Bayer AG

Boehringer Ingelheim GmbH

Bristol Myers Squibb Company

Pfizer Inc.

Additional Topics

Clinical Trials Approvals Regulation Post Market Regulation & Studies Drug Approval Standards BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window